OrsoBio
Palo Alto, CA
OrsoBio is a clinical-stage biopharmaceutical company that creates therapies for patients suffering from severe metabolic disorders such as diabetes, severe dyslipidemia, lipodystrophies, and others. OrsoBio is committed to restoring energy homeostasis in patients with severe metabolic disorders, in some cases, by targeting pathways relevant to maintaining energy balance. OrsoBio revolutionizes the treatment of these disorders by addressing the underlying cause.
orsobio.comCompany Details
Founded
- 2021
Employees
- Between 5 - 20 employees
Raised
- $62,300,000
Headquarters Location
- Palo Alto, CA
Public
- No
Acquired
- No
CEO
- N/A
Company Collections
These are collections OrsoBio is a part of. Click on the collection name to view similar companies.